Avian Bird Flu - The Quigley Corporation And The Israeli Ministry Of Agriculture (MOAG)

The Quigley Corporation And The Israeli Ministry Of Agriculture (MOAG) Will Collaborate To Test Quigley Pharma QR-441(a)
The Quigley Corporation (Nasdaq: QGLY) today announced that it has signed an agreement with the State of Israel Ministry of Agriculture & Rural Development (MOAG) and the Kimron Veterinary Institute to conduct a clinical trial testing the anti-viral capacity of the Quigley compound QR-441(a) administered as a medical feed and water to chickens exposed to HPAI (Highly Pathogenic Avian Influenza) H5N1. The QR-441(a) was developed by Quigley Pharma, [click link for full article]

Flu Shot Might Also Offer Some Protection Against H5N1
The yearly influenza vaccine that health officials urge people to get each fall might also offer certain individuals some cross protection against the H5N1 virus commonly known as bird flu, according to investigators at St. Jude Children's Research Hospital. [click link for full article]

WHO reports some promising results on avian influenza vaccines
Experts meeting over the past two days at the World Health Organization (WHO) on advances in pandemic influenza vaccine development reported encouraging progress.